receptor tyrosine-based activation motif (ITAM) capable of activating signaling pathways (26, 33, 34, 57, 61) . K1 protein is related to the immunoglobulin receptor family and has similarity to the B-cell receptor (33) . K1 is constitutively active through oligomerization via conserved, extracellular cysteine residues leading to the phosphorylation of the ITAM and recruitment of the major B-cell kinase Syk for the phosphorylation of cellular proteins, mobilization of intracellular calcium, and activation of transcription factors such as NFAT and AP-1 (21, 27, 28, 30, 33, 38, 58) . The amino-terminal domain of K1 interacts with the chain of the B-cell receptor complex leading to the inhibition of intracellular transport of B-cell receptor and resulting in retaining B-cell receptor complexes in the endoplasmic reticulum, preventing their intracellular transport to the cell surface which implies a role for K1 in the survival of KSHV-infected cells (26, 30, 32) .
The expression profile of K1 during the KSHV life cycle in not restricted to only the lytic cycle. Previous studies performed by Lagunoff and Ganem demonstrate that a 1.3-kb transcript is expressed only when BCBL-1 cells were induced with tetradecanoyl phorbol acetate (26) , whereas Samaniego et al. have shown the presence of a 1.3-and a 3-kb K1 transcript in uninduced BC-3 cells as well as their up-regulation in tetradecanoyl phorbol acetate-induced BC-3 cells (47) . The K1 FIG. 1. LANA down-regulates K1 promoter transcriptional activity. A. Strategy for cloning K1p into pGL3B. The NotI-BamHI fragment of cosmid Z6 containing K1 and the terminal repeat was excised and cloned into BSpuro at the indicated sites, generating pBSpuroB. The coding sequence of K1 was deleted by digesting with BamHI and PstI followed by blunting both ends and religating it to make pBSpuroBB. K1p was transcript has also been detected in Kaposi's sarcoma tumors as well as in multicentric Castleman's disease tissues (39, 47) .
Northern hybridization and microarray data analyzing KSHV's transcriptional program during lytic reactivation in primary effusion lymphomas and real-time PCR analysis indicate that K1 expression was up-regulated during the lytic cycle (16, 22, 25, 40, 48) . However, analysis of gene clusters based on transcriptional program groups K1 with the latency-associated nuclear antigen (LANA) gene cluster of Orf73, Orf72 (cyclin), and Orf71 (vFLIP) (16) . Based on the previous data it is believed that K1 is clearly up-regulated during the lytic cycle but there is a possibility of a low level of K1 expression during latent infection. A previous published report shows that ITAM-dependent signaling by K1 can boost lytic reactivation in KSHV-infected primary effusion lymphoma cells, determined by introducing K1 mutants into BCBL-1 cells, which diminished lytic cycle gene expression (27) . Therefore it is believed that K1 might have multiple roles in cellular signal transduction and viral lytic reactivation (27) .
Since the expression of K1 was mostly up-regulated during the lytic cycle Bowser et al. evaluated the role of RTA on a K1 promoter cloned by PCR amplification of K1p spanning the Ϫ325 to ϩ76 region including part of the terminal repeat sequences (4) . In this report we have evaluated the effect of LANA on K1p activity by cloning the promoter region including the LANA binding sequence. We demonstrate that the K1 promoter element was down-regulated in the presence of LANA, which explains the reduced or minimal levels of K1 during latent infection. We have further demonstrated that RTA can rescue LANA-mediated down-regulation of K1p in a dose-responsive manner and thus may contribute to control the lytic reactivation of KSHV.
MATERIALS AND METHODS
Promoter cloning and plasmids. We digested previously described cosmid Z6 with BamHI and NotI and precisely excised a 2,315-bp band which includes the region of the first terminal repeat and the entire K1 open reading frame (ORF) (9, 45) . The fragment was cloned into pBSpuro, resulting in pBSpuroB, which was further digested to remove the K1 ORF region with PstI (enzyme site immediately after translation start site) and BamHI. The plasmid was end blunted and ligated to generate pBSpuroBB containing the K1 promoter region. The K1 promoter region (Ϫ650 to ϩ76), including the untranslated region, was excised by NotI, followed by end-filling and HindIII digestion. This fragment was cloned into the pGL3basic vector that had been digested with BglII, end filled to blunt the site using the Klenow fragment, and then digested with HindIII, generating pGL3B K1p(Ϫ650 to ϩ76) (Fig. 1A) .
The promoter element deleted of the LANA binding sequence was generated by deleting the SmaI fragment from the above promoter and designated pGL3B K1p(Ϫ350 to ϩ76). pGL3B K1p(Ϫ116 to ϩ76) deleted of potential RTA binding sequence (interleukin-6 promoter region) was generated by digesting the above Ϫ350 to ϩ76 construct with AscI, followed by blunting this site and digesting the vector backbone again with SmaI to remove the region of the promoter from Ϫ350 to Ϫ115. Self-ligation of the remainder of the vector yielded pGL3B K1p(Ϫ116 to ϩ1). The promoter region from Ϫ116 to ϩ76, including the untranslated region, was analyzed for transcription factor binding motifs using an online motif search tool (http://motif.genome.jp/). Oct-1 transcription factor binding sites were mutated by site-directed mutagenesis using PCR primers containing the desired mutations. All the clones were sequenced and confirmed for the presence of indicated mutations.
pA3M LANA and RTA Myc were used as expression vectors for LANA and RTA and were described previously (29, 37, 56) . LANA mutants LANA N (amino acids 1 to 340), LANA C (amino acids 762 to 1162), and LANA ⌬IR (amino acids 327 to 929 deleted) used in reporter assay were described previously (54) .
pBSpuro was made by cloning the puro cassette at the SalI and ClaI sites of pBS (Stratagene). The expression vector containing K1p under control of its endogenous promoter, pBSpuroB, was made as described above. Plasmid pBSpuroB ⌬LBS, with K1 gene expression under the control of endogenous K1p deleted of LANA binding sites (LBS), was generated by removing the NotI and SmaI fragment of pBSpuroB. pCDNA3.1 K1 was generated by PCR amplification using pBSpuroB as template DNA.
Cell lines. BCBL-1 is a KSHV-positive primary effusion lymphoma cell line. BJAB, KSHV-negative cells were cultured in RPMI supplemented with 7% fetal bovine serum, 2 mM L-glutamine and penicillin-streptomycin (5 U/ml and 5 g/ml, respectively). Human embryonic kidney 293 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and penicillin-streptomycin (5 U/ml and 5 g/ml, respectively).
Antibodies. Myc-tagged proteins were detected using mouse hybridoma 9E10 described previously (56) . Beta-actin was detected using rabbit anti-␤-actin antibody (Cell Signaling, Beverly, MA). Lyn and phospho-Lyn (S507) were detected using specific antibodies (Cell Signaling, Beverly, MA).
Reporter assay. Reporter assays were performed in 293 and BJAB B cells; 10 million 293 and BJAB cells were transfected using a Bio-Rad electroporater (Bio-Rad Laboratories); 5.0 g of the indicated reporter plasmids was transfected along with indicated amounts of LANA and RTA expression vectors. pA3M empty vector was used as filler DNA. Transfection efficiencies were normalized using the green fluorescent protein-containing vector pEGFPC1 (Clontech Inc., Palo Alto, CA). At 24 h posttransfection cells were harvested, washed in phosphate-buffered saline and lysed in cell lysis buffer (Bio-vision); 50 l of cell lysate was used for the reporter assay using a Luminometer LMX384 (Molecular Devices, CA).
A portion of the cell lysate was used for Western blotting. Transferred proteins were detected by Odyssey infrared scanning technology (LiCor, Lincoln, NE.) using Alexa Fluor 680 and Alexa Fluor 800 (Molecular Probes, Carlsbad, CA, and Rockland, Gilbertsville, PA, respectively). Empty vector pGL3B showed some up-regulation with RTA expression and therefore the fold change in reporter plasmid with RTA is normalized with the empty vector. All the transfections were done in duplicate and the results shown represent the mean of the data from three independent experiments.
Reporter assays were also performed by transfecting the above plasmids into 293 cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA); 300 ng of indicated reporter plasmids was transfected with 500 ng of LANA and RTA expression vectors using 1.0 l of Lipofectamine as per the manufacturer's instructions. At 24 h posttransfection cells were harvested and subjected to the reporter assay and Western blot analysis.
Quantitation of K1 transcript. pBSpuro, pBSpuroB (Ϫ650 to ϩ76 K1p and ORF) and pBSpuroB ⌬LBS (Ϫ350 to ϩ76) was cotransfected into 10 million HEK293 or BJAB cells with LANA, RTA or both by electroporation; 36 h posttransfection cells were harvested and divided into two sets. The first set was excised from pBSpuroBB by digesting with NotI followed by blunting and digesting with HindIII. The excised fragment was cloned into pGL3B at the BglII (blunted) and HindIII sites. B. Schematic of K1p(Ϫ650 to ϩ76) and LBS-deleted K1p(Ϫ350 to ϩ76), generated by digesting pGL3BK1p with SmaI to remove the LBS region followed by religation of the remaining vector. C. LANA down-regulates K1p(Ϫ650 to ϩ76) activity. pGL3B K1p(Ϫ650 to ϩ76) was cotransfected with increasing amounts of LANA (5, 10, and 15 g) into 293 cells. At 24 h posttransfection cells were lysed and assayed for luciferase activity. Increasing amounts of LANA showed down-regulation of K1p, whereas increasing amounts of RTA (5, 10, and 15 g) up-regulated the promoter. Increasing amounts of LANA and RTA were detected in the respective cell lysates by Western blotting using anti-Myc antibody. D. LBS-deleted K1p(Ϫ350 to ϩ76) is unaffected by LANA-mediated down-regulation. Increasing amounts of LANA and RTA were cotransfected with K1p ⌬LBS and assayed for luciferase activity. Increasing amounts of LANA show slight up-regulation of K1p, whereas RTA showed a similar up-regulatory effect on full-length K1p. E. LANA down-regulates full-length K1p(Ϫ650 to ϩ76), whereas RTA up-regulates the promoter in BJAB cells in a dose-dependent manner, similar to 293 cells. F. LANA and RTA show similar effects on LBS-deleted K1p(Ϫ350 to ϩ76) transcriptional activity in BJAB cells.
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for the isolation of total RNA and the second set was used for Western detection of Lyn, phospho-Lyn, and ␤-actin using specific antibodies. Lyn and phosphoLyn were subsequently detected with Alexa Fluor 680 and Alexa Fluor 800 secondary antibodies using Odyssey Infra-Red scanning technology (LiCor, Lincoln, NE). Band intensities were quantified using Odyssey software v1.2 (LiCor, Lincoln, NE) and relative intensities were calculated considering lane 1 of each set as the reference. Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. cDNA was synthesized using a first-strand cDNA synthesis kit (Invitrogen, Carlsbad, CA) as per the manufacturer's recommendations. K1 gene-specific primers Forward (5Ј-CCAAACGG ACGAAATGAAAC-3Ј) and Reverse (5Ј-ACGTGTGGTTGCATGGATTA-3Ј) were used for amplification and quantitation of K1 transcripts in synthesized cDNA. Amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) with specific primers (Forward, 5Ј-TGCACCACCAACTGCTTAG-3Ј, and Reverse, 5Ј-GATGCAGGGATGATGTTC-3Ј) was used for the normalization of Ct values in different samples.
Amplification was performed using SYBR Green real-time master mix (MJ Research Inc., Waltham, MA), 1 mM each primer, and 1 l of the cDNA product in a total volume of 20 l. Thirty cycles of 1 min at 94°C, 1 min at 56°C, and 30 s at 72°C, followed by 5 min at 72°C, were performed in an MJ Research Opticon II thermal cycler (MJ Research Inc., Waltham, MA). Each cycle was followed by two plate reads, the first at 72°C and the second at 82°C. A melting curve analysis was performed to verify the specificity of the amplified product. K1 transcripts were calculated using pCDNA3.1 K1 purified plasmid as a standard. The experiment was done in triplicate and the data presented here are the means of two independent experiments.
Primary infection of HEK293 cells with KSHV in vitro. KSHV was purified from BCBL-1 as described previously (29) . Approximately 50 million cells were induced with 20 ng of tetradecanoyl phorbol acetate/ml and 1.5 mM sodium butyrate (Sigma, St. Louis, MO) for 5 days. Medium containing virion particles was centrifuged to remove cell debris, followed by filtering through 0.45-m syringe filters. Virions were pelleted at 20,000 rpm for 2 h and resuspended in 1ϫ phosphate-buffered saline; 10 million 293 cells were infected at the 25% confluent stage and cells were harvested at the indicated time points. Total RNA was extracted and used for cDNA synthesis using a first-strand cDNA synthesis kit (Invitrogen, Carlsbad, CA). Gene-specific primers were used for the amplification of K1 used in the previous experiment. The LANA-and RTA-specific primers for real-time quantitation used were described previously (29) . The values for the relative copies were calculated by the ⌬⌬C t method using the ␤-actin gene as the control. Each sample was analyzed in triplicate.
Electrophoretic mobility shift assay. Oligonucleotides containing the Oct-1 site or mutated Oct-1 site were synthesized and annealed to the respective antisense strand by gradient cooling. The double-stranded DNA probe was filled in with ␣-32 P-labeled dCTP, dATP, dGTP, and dTTP using the Klenow fragment (New England Biolabs, Beverly, MA). The labeled probes were purified on a Nuc Trap probe purification column (Stratagene Inc., La Jolla, CA) according to the manufacturer's instructions. The total incorporation of [␣-32 P]dCTP was measured, and approximately 75,000 cpm of probe was used per reaction.
Nuclear extracts prepared from BCBL-1 cells were used as a source of Oct-1 transcription factor. In vitro-translated RTA prepared by the coupled in vitro transcription/translation system (TNT) of Promega Inc. (Madison, WI) according to the manufacturer's instructions was used in the indicated lanes. Anti-Oct-1 antibody (Santa Cruz Biotechnology) was used for supershift analysis.
Nuclear extract (5.0 g of total protein) was used for binding to the indicated probe in electrophoretic mobility shift assay reactions. Unlabeled competitor (100-fold) was added 5 min prior to the addition of radiolabeled probes; 1.0 g of rabbit anti-Oct-1 was used to supershift the complex. The protein-DNA binding reaction mixture was incubated at 25°C for 15 minutes. The bound complex was loaded onto a 6.0% polyacrylamide gel containing 0.5ϫ TBE (0.045 M Tris-borate, pH 8.2, 1 mM EDTA). The gel was resolved in 0.5ϫ TBE for 4 h at 150 V, dried, and autoradiographed using a PhosphorImager plate (Molecular Dynamics, Inc.).
RESULTS
LANA down-regulates the K1 promoter in the reporter assay. KSHV-encoded K1 is the first open reading frame shown to be expressed predominantly during the lytic cycle of the virus with the exception of low levels during latency (16, 26, 37) . The role of K1 in tumorigenesis is clearly established by various laboratories but the regulation of K1 expression during latent and latent/lytic switch is not well understood (34, 42) . One study done so far has demonstrated that the Ϫ125 to ϩ76 region was sufficient and responsive to RTA expression (4), but did not explore the regulation of K1 expression during latent infection.
Sequence analysis of the K1 promoter region cloned from the Z6 cosmid revealed the presence of LANA binding sequence upstream of bp Ϫ325 previously described as a promoter (4). Since LANA is expressed in almost all KSHV-positive cells and important for tethering of the viral genome by binding to the LANA binding sequence (2, 10, 19, 20, 26) , we hypothesized that LANA may have a role in regulation of K1 expression.
We digested cosmid Z6 of KSHV with BamHI and NotI and cloned K1p as described in the schematic (Fig. 1A) . In order to determine the effect of LANA on K1p, we cotransfected pGL3B K1p(Ϫ650 to ϩ76) with the LANA expression vector in HEK293 as well as in BJAB cells and assayed promoter activity as relative luciferase units. Reporter assays performed using pGL3B K1p(Ϫ650 to ϩ76) with LANA showed a decrease in promoter activity which was further decreased in a dose-dependent manner with increasing LANA expression (Fig. 1C) . LANA-dependent down-regulation of K1p was similarly observed in BJAB cells with increasing amounts of LANA (Fig. 1E) . However, RTA, which was previously shown to up-regulate K1p (4), showed dose-dependent up-regulation of the full-length K1 promoter activity in both the 293 and BJAB cell lines ( Fig. 1C and E) .
LANA binding sequence in K1p is important for LANAmediated down-regulation. It has clearly been demonstrated that LANA binds to its cognate sequence within the terminal repeat with high affinity to at least one binding site, LBS1 (19) . Therefore, we were interested in determining the effect of LANA on K1p deleted for the LANA binding sequence, pGL3B K1p ⌬LBS (Ϫ350 to ϩ76) (Fig. 1B) . Cotransfection of reporter plasmid with the LANA expression vector did not show any down-regulation of the promoter activity in either of the cell lines tested, 293 or BJAB (Fig. 1D and F) . Increasing amounts of LANA expression with the pGL3B K1p ⌬LBS (Ϫ350 to ϩ76) reporter plasmid revealed a small but noticeable up-regulation in promoter activity with increasing LANA expression ( Fig. 1D and E) . However, transcriptional activity of LBS-deleted K1p (pGL3B K1p ⌬LBS) in the presence of RTA was similar to that on full-length K1p(Ϫ650 to ϩ76) ( Fig.  1D and E). LANA and RTA expression was detected using the anti-Myc antibody, as these expression plasmids were carboxylterminally fused with the Myc epitope.
RTA prevents LANA-mediated down-regulation of K1p transcriptional activity. Our reporter assay data suggested that LANA can down-regulate K1 expression and it has been clearly shown that LANA is expressed in almost all infected cells during latent infection and tethers the viral genome to the host chromosomes (1, 9) . Therefore, it is most likely that binding of LANA to its cognate sequence can repress K1 expression. In order to determine whether RTA is able to up-regulate K1 expression when LANA is bound to its cognate sequence we cotransfected pGL3B K1p(Ϫ650 to ϩ76) along with constant amounts of LANA in the indicated lanes and increasing amounts of RTA. Reporter assays performed 24 h posttransfection with the cell lysates showed that RTA can prevent LANA-mediated repression of K1p and in fact was up-regulated with increasing RTA expression ( Fig. 2A, lanes 3 and 4) . Cotransfection of similar amounts of LANA and RTA with LBS-deleted K1p(Ϫ350 to ϩ76) showed enhanced up-regulation in K1p, suggesting a cooperative effect of LANA and RTA on the truncated promoter (Fig. 2B ). LANA and RTA in all these reporter assays were detected by Western blot using the anti-Myc antibody. Carboxyl terminus of LANA is sufficient for down-regulation of K1p(؊650 to ؉76). Previous studies have demonstrated that the C terminus of LANA contains the DNA binding domain; therefore we wanted to determine whether the binding domain by itself is sufficient for K1p down-regulation. Thus, we cotransfected different truncated mutants of LANA for the reporter assay along with full-length K1p(Ϫ650 to ϩ76) as well as LBS-deleted K1p(Ϫ350 to ϩ76). Our reporter assay data showed that the C terminus of LANA (amino acids 762 to 1162) had down-regulatory effects similar to those of fulllength LANA, suggesting that the carboxyl terminus is sufficient to down-modulate K1p by binding to its cognate sequence of the promoter (Fig. 3A) .
The N terminus of LANA did not have any noticeable effect on transcriptional modulation, whereas the LANA truncation mutant deleted of the middle glycine/glutamic acid region (⌬IR; amino acids 327 to 929 deleted but containing both the amino-and carboxyl-terminal domains) up-regulated K1p (Fig. 3A) . K1p deleted of the LBS (Ϫ350 to ϩ76) upon transfection with LANA showed similar up-regulation in promoter activity, whereas neither the amino nor the carboxyl terminus of LANA was able to modulate its activity to any noticeable level above that of the control (Fig. 3B) . The LANA truncation mutant (⌬IR) up-regulated the promoter like full-length LANA, suggesting that both the amino and carboxyl termini of LANA are important for up-regulation but binding of the LANA carboxyl terminus to the K1p region is important for down-regulation.
LANA and RTA modulate K1 transcription level from the native endogenous viral promoter element. We used pBSpuro B containing the entire K1p(Ϫ650 to ϩ76) and its coding sequence for cotransfection with expression vectors of LANA, RTA, or both together into 293 and BJAB cells. Cells were harvested 36 h posttransfection for the isolation of total RNA followed by cDNA synthesis. Transcripts detected using realtime quantitative PCR showed almost 1.5-fold-reduced numbers of K1 transcripts in LANA-and pBSpuroB-cotransfected 293 cells (Fig. 4A, lanes 1 and 2) . BJAB cells cotransfected with LANA and the above promoter (pBSpuroB) showed an almost twofold reduction in K1 transcripts at 36 h posttransfection (Fig. 4B, lanes 1 and 2) . This corroborated our reporter assay data for both the 293 and BJAB cell lines. RTA, which was shown previously to up-regulate the K1 promoter as well as in our reporter assay, showed 1.5-to 2.5-fold increases in K1 transcript levels in 293 and BJAB cells, respectively. Cotransfection of the LANA and RTA expression vector together with pBSpuroB showed a moderate reduction in K1 transcripts which may be due to the antagonistic role of LANA on RTAmediated K1p transcriptional up-regulation.
We also used LANA binding site-deleted K1p as the native viral promoter upstream of the K1 ORF and cotransfected it with LANA and RTA for detection of K1 transcripts. LANAtransfected 293 and BJAB cells showed moderate increases in K1 transcripts, whereas RTA transfection showed a significant (twofold) increase in the levels in both cell lines (Fig. 4A and  B) . Cotransfection of LANA and RTA together with LBSdeleted K1p showed significant increases in levels of K1 transcripts in 293 as well as BJAB cells, corroborating the reporter assay data. cDNA made from vector (pBSpuro)-transfected 293 and BJAB cells did not show any amplification using genespecific primers for K1 (data not shown).
Further, we wanted to determine the phosphorylation state of Lyn in cells expressing K1 from its endogenous promoter and the effect of LANA and RTA on K1 expression and Lyn phosphorylation. K1 was previously shown to be increased in K1 transgenic mice (42) . Protein extracted from 293 and BJAB cells cotransfected with pBSpuroB and LANA or RTA showed various levels of Lyn phosphorylation (relative band intensities are shown at the bottom of each band). Detection of phosphoLyn in pBSpuroB-and LANA-transfected 293 as well as BJAB cells showed reduced levels of Lyn phosphorylation ( Fig. 4A and B, relative change in band intensity of lanes 1 and 2 in the Lyn and phospho-Lyn panels). 293 and BJAB cells cotransfected with RTA and pBSpuroB showed a slight increase in the phosphorylation of Lyn which may be due to the increased K1 expression, thus corroborating the above data ( Fig. 4A and B, relative change in band intensity of lanes 1 and 3 in the Lyn and phospho-Lyn panels). Expression of LANA and RTA along with pBSpuroB did not show a significant difference in phosphorylation of Lyn (Fig. 4A and B, lane 4 in the Lyn and phospho-Lyn panels).
The K1 gene under control of the deleted LBS (Ϫ350 to ϩ76) promoter showed slight increases in the phosphorylation of Lyn upon cotransfection with either LANA or RTA compared to no LANA or RTA, suggesting that increased K1 might have enhanced the phosphorylation of Lyn (Fig. 4A and B, Ϫ350 to ϩ76 panels, compare lane 1 with lanes 2 and 3). Expression of LANA and RTA together with the above promoter showed enhanced Lyn phosphorylation, corroborating the above data ( Fig. 4A and B, lane 4) . Transfection of LANA and RTA with the pBSpuro vector control in 293 and BJAB showed little or no change in relative levels of Lyn and phospho-Lyn in cells transfected with LANA, RTA, or both. This suggests that modulations in the phosphorylation of Lyn were due to the various levels of K1 expression. Expression of LANA and RTA was detected by Western blot analysis using anti-Myc antibodies. Blots were stripped and probed for ␤-actin as a control for protein loading.
Levels of K1 transcript increase during early infection, followed by rapid reduction towards the establishment of latency. We used purified BCBL-1 virions to infect 293 cells and folpBSpuroB and LANA showed reduced numbers of K1 transcripts as well as reduced levels of phospho-Lyn (lanes 1 and 2) . RTA showed increased numbers of K1 transcripts as well as phospho-Lyn levels (lane 3). Cells transfected with both LANA and RTA showed similar slight modulations in Lyn phosphorylation in BJAB cells (lane 4). pBSpuroB ⌬LBS showed enhanced Lyn phosphorylation in cells transfected with both LANA and RTA. The pBSpuro vector alone did not show much change in phospho-Lyn levels with LANA or RTA coexpression.
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on June 24, 2017 by guest http://jvi.asm.org/ lowed the pattern of K1 transcripts levels during early infection up until 72 h. Total RNA was extracted from these infected cells at the indicated time points and detection of LANA, RTA and K1 transcripts levels is shown in Fig. 5 . The expression levels of K1 peaked at 24 h, followed by a steady decline observed until 72 h postinfection. The LANA levels were increased by 12 h and remained at a high level after 24 h of infection. K1 and RTA mRNA levels were maintained at the same low level, likely due to the small subset of KSHV-infected cells which spontaneously undergo lytic replication. The rapid decrease in the levels of K1 and RTA transcripts is likely due to LANA activating its own expression and repressing transcriptional activity of the lytic genes. LBS-deleted K1p(؊350 to ؉76) contains an interleukin-6 promoter-like RRE element. Our reporter assay data indicated that LANA-mediated repression of K1p is due to the presence of its cognate sequence and most probably LANA binding to this region. We further looked to map the RTA-mediated responsive region on K1p. We aligned the Ϫ350 to ϩ76 sequence of K1p with the sequence of known binding sites of RTA (12) . In our sequence alignment analysis we found a region on K1p having significant similarity to the RTA response elements (RRE) present in the interleukin-6 promoter (Fig. 6) .
In order to evaluate the effect of RTA, we made a mutant promoter by deleting the potential RRE element [K1p(Ϫ116 to ϩ76)]. Reporter analysis with RTA revealed that the Ϫ116 to ϩ76 region of the promoter was sufficient for RTA-mediated up-regulation, suggesting some other mechanism of RTA-mediated K1p activation (Fig. 6) . Coexpression of LANA with the Ϫ116 to ϩ76 promoter region showed a slight increase in promoter activity (Fig. 6 ). Full-length K1p(Ϫ650 to ϩ76) and LBS-deleted K1p(Ϫ350 to ϩ76) were used parallel to the Ϫ116 to ϩ76 region in this experiment (Fig. 6) . Expression of LANA and RTA was detected by Western blot analysis using anti-Myc antibody.
Sequence analysis of the ؊116 to ؉76 region of K1p revealed Oct-1 transcription factor binding sites. In order to determine the specific transcription factor binding sites located within the Ϫ116 to ϩ76 elements we scanned the indicated region which also includes the first start codon using a webbased motif search tool. The result revealed the presence of multiple Oct-1 transcription factor binding sites shown in Fig.  7A (Oct-1 binding sites shown are shown in expanded boxes).
We mutated these potential Oct-1 transcription factor binding sites individually as well as all three together by site-directed mutagenesis (Fig. 7B, C, D, and E) . Reporter analysis performed in 293 cells demonstrated that loss of the first Oct-1 site reduced RTA-mediated responsiveness to 50%, suggesting that this site contributes a significant amount of activity to the promoter (Fig. 7B, I Oct-1 mut) . Mutation of the second Oct-1 site reduced RTA responsiveness to 30%, whereas mutation of the third Oct-1 site was unaffected by RTA-mediated up-regulation ( Fig. 7C and D) . Mutation of all three Oct-1 sites reduced the RTA-mediated responsiveness to 25%, suggesting that Oct-1 transcription factor binding sites contribute signifi-FIG. 7. Oct-1 sites are important for RTA-mediated up-regulation of K1p. A, Schematic showing the presence of Oct-1 transcription factor binding sites in the Ϫ116 to ϩ76 region of K1p. B, C, and D, Oct-1 transcription factor binding sequences I, II, and III. The top strand is the sequence in K1p and the bottom strand is the mutated sequence incorporated by site-directed mutagenesis. E, K1p Ϫ116 to ϩ76 with all Oct-1 sites mutated. Reporter assays performed in 293 cells with pGL3B K1p Ϫ116 to ϩ76 (pGL3B-A), Oct-1 site I mutated (pGL3B-B), Oct-1 site II mutated (pGL3B-C), Oct-1 site III mutated (pGL3B-D), and all three Oct-1 sites mutated (pGL3B-E) with LANA and RTA. All Oct-1 site-mutated promoters had significantly reduced (80%) relative luciferase activity (E). The Oct-1-mutated promoters had different basic transcriptional activities which were normalized, and relative fold changes are plotted here. Representative Western blots show expression of LANA and RTA in the above transfections.
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on June 24, 2017 by guest http://jvi.asm.org/ cantly to the RTA-mediated up-regulation of the K1 promoter (Fig. 7E) . Representative Western blots for LANA and RTA expression are shown in Fig. 7F . Sp1 transcription factor binding sites were not responsible for RTA-mediated up-regulation but important in LANAmediated up-regulation. Sequence-scanning analysis also demonstrated the presence of multiple Sp1 transcription factor binding sites within Ϫ116 to ϩ76, similar to a previous report (4) . We wanted to further determine whether these sites may in fact play a role in RTA-mediated up-regulation of the promoter. A deletion excising all Sp1 transcription factor binding sites was generated (Fig. 8) . Reporter analysis of this construct performed in the presence of the RTA expression vector revealed that there was a negligible change in RTA-mediated responsiveness, suggesting that Sp1 sites were not the critical sites for modulation (Fig. 8 ). However, the low level of activation by LANA was abolished in the Sp1-deleted promoter construct, suggesting that LANA may have this activity through binding to Sp1 transcription factors. Deletion of Sp1 sites in the third Oct-1 mutated reporter construct (retaining the second Oct-1 site) Ϫ116 to ϩ76 promoter region clearly demonstrated that most of the RTA-mediated response is due to the second Oct-1 transcription factor binding site (Fig. 8C) .
Oct-1 transcription factor binds to cis-acting elements within the K1p promoter region. We performed electrophoretic mobility shift assays to demonstrate the binding of cellular Oct-1 to nucleotide sequences within K1p. We used oligonucleotide probes comprising the second Oct-1 site as well as a mutated site as the probe. Labeled probes were incubated with BCBL-1 cell nuclear extract which showed a specific shift in the mobility of probe (Fig. 9, lane 2) . The shift in mobility was abolished using 100-fold specific unlabeled competitor, suggesting the specificity of binding (Fig. 9, lane 3) . Mutated nonspecific unlabeled competitor was unable to abolish the Oct-1-specific shift, suggesting that the mutation in the Oct-1 site abolished binding of the Oct-1 transcription factor.
Oct-1-specific binding was further confirmed by using antiOct-1 antibody to supershift the Oct-1-DNA complex (Fig. 9,  lane 5) . Nonspecific immunoglobulin G antibody did not have any effect on the mobility of the Oct-1-DNA complex and Oct-1-specific antibody by itself did not show any binding to DNA (Fig. 9, lanes 6 and 7, respectively) . Addition of in vitrotranslated RTA to the Oct-1-DNA complex did not show any change in the mobility of the complex, suggesting that RTA does not have a strong affinity for Oct-1 bound to DNA. Similar amounts of rabbit reticulocyte lysate were also unable to modulate the shift in mobility. In vitro-translated RTA by itself also did not bind to the probes (Fig. 9, lane 10) . Thus, the activity of K1p mediated by RTA is most likely occurring through the specific Oct-1 sites by the interaction of Oct-1 and RTA, or by recruitment of additional activators and coactivators. Further studies to elucidate this possibility are ongoing.
DISCUSSION
Kaposi's sarcoma-associated herpesvirus persists episomally in infected cells by tethering the viral genome to the host chromosome (1, 9). During latent infection only a small subset of genes important for maintaining viral latency by modulating various cellular pathways are expressed (3, 14, 24, 25, 51, 60) . Latency-associated nuclear antigen is one of the prominent proteins detected in all forms of latency and shown to be critical for maintenance of latency (1, 9, 17, 25, 43) . K1, a transmembrane glycoprotein expressed mostly during lytic infection, contains an extracellular domain and a C-terminal cytoplasmic tail immunoreceptor tyrosine-based activation motif (26, 33, 34, 57, 61 (38) . Cloning and sequence analysis of the NotI-BamHI fragment of cosmid Z6 revealed the presence of LANA binding sequences in the K1p region which was not previously explored for K1 expression (4). However, terminal-repeat-mediated transcriptional activity has been shown to be repressed by LANA expression (35) . Also, K1 mRNA has been detected at low levels in latently infected primary effusion lymphoma cell lines (16) . Our reporter assay data for the full-length promoter (Ϫ650 to ϩ76) compared to LBS-deleted K1p showed a small increase in K1p activity compared to the wild type with LANA, suggesting that binding of LANA to its cognate sequence contributes to the down-modulation of K1p transcription. This may partially explain why K1 mRNA is at very low levels during latent infection as LANA binds to its cognate sequence to tether the viral genome to the host chromosomes (55) .
It would be interesting to see the levels of K1 mRNA in primary effusion lymphoma cell lines lacking LANA using small interfering RNA or binding of LANA to its cognate sequence with the use of the dominant negative LANA carboxyl terminus. However, knocking down LANA may not be conclusive for K1 expression because LANA depletion leads to the expression of RTA and related genes and RTA by itself has been shown to up-regulate K1p (4, 29) . Thus, the up-regulation of K1p transcriptional activity in LANA-depleted primary effusion lymphoma cell lines will be mainly because of RTA.
Binding of LANA to the LBS is likely to be the primary reason for its repressive activity, as LANA lacking the DNA binding domain did not repress K1p. Additionally, the C terminus of LANA, which is the binding domain for DNA, repressed K1p as full-length LANA did, confirming our hypothesis. Surprisingly, LANA containing both the amino and carboxyl termini fused in frame (LANA ⌬IR) was unable to repress K1p transcriptional activity in our reporter assays even though this contained the DNA binding domain. This may be due the fact that LANA lacking glutamine and glutamic acid residues has been demonstrated to have higher transcriptional activity than full-length LANA (54, 59) . Thus, the repressive effect due to the binding of LANA-C may be overridden by increased transcription regulation by LANA ⌬IR (Fig. 4) .
The effect of LANA on the transcriptional activity of K1p was further confirmed by using the K1 ORF under the control of its own promoter and determining the copies of K1 mRNA. This corroborated the luciferase reporter assay data showing that LANA reduced the transcription of the K1 gene. Additionally, RTA-mediated up-regulation of K1p transcription was confirmed at the mRNA level and was unaffected by deletion of the LBS sequence from the promoter region, unlike LANA, which lost its repression ability in the LBS-deleted promoter region.
Increased transcriptional activity of K1p and thus enhanced K1 expression was further confirmed by looking at levels of cellular Src homology 2-containing signaling protein Lyn. Increased K1 expression has been shown to induce phosphorylation and activation of cellular Src homology 2-containing signaling protein Lyn and other cellular signaling kinases (38, 41) . Analysis of active phospho-Lyn levels in 293 and BJAB cells in the presence of LANA and RTA along with the K1 ORF under the control of its own promoter showed modulation in phospho-Lyn levels. The reduction in phospho-Lyn levels is most likely due to the reduced levels of K1 expression as there were no significant changes in phospho-Lyn levels in the cells expressing LANA only. Reduced levels of phospho-Lyn may repress the downstream signaling activities, including phospholipase C␥/Ca 2ϩ pathway activation, thus establishing latency (38) . However, previous studies have demonstrated ITAM tyrosine phosphorylationindependent Syc phosporylation and NFAT reporter activation, suggesting that Syc is not the only effector of K1 signal transduction (28, 38) . Additionally, K1-transgenic mice have been shown to have increased active Lyn kinase but not Syc kinase in splenic B lymphocytes, supportive for Syc-independent phosphorylation of Lyn (38, 42) . In contrast to LANA, RTA showed increased levels of active phospho-Lyn and thus possible enhancement of the lytic cycle (38) .
Detection of increased phospho-Lyn levels in LANA-and RTA-coexpressing cells with the homologous promoter-driven K1 gene suggests that RTA has strong up-regulatory effects, thus preventing LANA-mediated down-regulation, which corroborates the reporter assay data. Interestingly, we have observed reduced levels of LANA in RTA-expressing cells even though they were expressed from the same heterologous promoter. Therefore one might argue that RTA-mediated rescue may be due to degradation or reduced amounts of LANA in the cells. This needs to be further addressed by exploring the stability of LANA in the presence of RTA.
Our infection assay and time course detection of K1 mRNA demonstrated that K1 transcripts can be detected at about the same time as RTA and the level is suppressed with the persistence of infection, similar to previous observations (37, 40) . This indicates that K1 might be playing an important role during initial lytic replication for the establishment of latency by mediating signaling of a productive infection (38) . K1 might also be important for signaling to produce cytokines which mediate paracrine effects, thus influencing neighboring uninfected as well as infected cells and KSHV-associated pathogenesis (38) . During the progression of latency, LANA mRNA increases, producing sufficient molecules for tethering the viral genome and thereby influencing the activity at the K1 promoter.
This study as well as previous studies have shown that RTA can modulate K1p (4). However, we were interested in delineating the promoter region responsive to RTA. Our reporter deletion analysis showed that the Ϫ116 to ϩ76 region of the promoter was sufficient for RTA-mediated up-regulation. Interestingly, a previous study has also demonstrated that the Ϫ125 to ϩ76 region of the promoter was efficiently modulated by RTA in various cell lines (4) . Sequence analysis of the Ϫ116 to ϩ76 region, which includes untranslated sequence up to the translation start site, revealed the presence of Oct-1 transcription factor binding sites as well as multiple sites for Sp1 transcription factor binding (4) .
Oct-1 belongs to the POU family and both Oct-1 and -2 can specifically interact with the octamer binding sequence ATG CAAAT (53) . Since Oct-1 was shown previously to be the important transcription factor binding site in the RTA promoter region responsible for RTA-mediated autoregulation (46), we focused on addressing their role by mutating these binding sites. The promoter region (Ϫ116 to ϩ76) mutated for the Oct-1 site showed a marked decrease in RTA responsiveness, suggesting that binding of Oct-1 is important for RTAmediated up-regulation. This again did not clearly demonstrate whether up-regulation is due to direct tight binding of RTA to Oct-1 or a likely weaker binding shown for RTA (46) .
The herpes simplex virus type 1 VP16 and varicella-zoster virus ORF10 proteins form a tight complex easily detected by electrophoretic mobility shift assay, with Oct-1 for activation of the target genes (36, 52) . However, RTA has been shown to up-regulate genes even without forming a tight complex with Oct-1 (46) . Sequence analysis showed that the Oct-1 sites identified have approximately 80% similarity to the Oct-1 consensus sequence and are bound by Oct-1 transcription factors. Therefore these sites may be critical to or contribute a major portion of K1 up-regulation.
In conclusion, the LANA binding sites of K1p are important for limited expression of K1 during latent infection as well as during the latent/lytic switch. RTA reverses the LANA-mediated repression of K1p and up-regulates K1 and its mediated FIG. 10 . Regulation of K1 expression during latent and lytic replication cycles. LANA tethers the viral genome to the host chromosome through binding to its cognate sequence within the terminal repeat (TR) (2, 10) . Binding of LANA to the terminal repeat promoter region of K1 down-regulates K1 expression and therefore down-regulates K1-mediated signaling and thus helps in maintaining latency. On the onset of lytic replication, the immediate-early gene RTA reverses LANA-mediated down-regulation of K1p partly through Oct-1 binding sites, thus elevating K1 levels. Up-regulation of K1 most likely leads to up-regulation of downstream K1-interacting kinases, including a number of cellular Src homology 2-containing proteins, leading to the up-regulation of downstream signaling and intracellular calcium mobilization and NFAT activation, which favors viral lytic replication (31, 38) .
signaling, thus contributing to the enhancement of lytic replication (Fig. 10) .
